Philipp Spycher, Ph.D. is the co-founder and CEO of Araris Biotech AG. As the inventor of the Araris Linker Technology, Philipp has a profound background in Bioconjugation and ADCs. He obtained his master’s degree and Ph.D. from ETH Zurich at the interface of Material Science and Protein Engineering. During his post-doctoral work at PSI, Dr. Spycher introduced the novel approach using transglutaminases for antibody conjugation that led to the discovery of the Araris Linker Technology.
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.